48,466
edits
(4 intermediate revisions by the same user not shown) | |||
Line 12: | Line 12: | ||
**Scant-to-moderate cytoplasm.<ref name=pmid12861057/> | **Scant-to-moderate cytoplasm.<ref name=pmid12861057/> | ||
**Small/indistinct nucleoli. | **Small/indistinct nucleoli. | ||
Note: | |||
*May look like Gleason pattern 3 adenocarcinoma. | |||
DDx:<ref name=pmid21606823/> | DDx:<ref name=pmid21606823/> | ||
Line 23: | Line 26: | ||
==IHC== | ==IHC== | ||
Features:<ref name=pmid21606823/> | Features:<ref name=pmid21606823/> | ||
*PAX8 +ve. | *[[PAX8]] +ve. | ||
*PSA -ve (all). | *[[PSA]] -ve (all). | ||
*PSAP -ve.<ref name=pmid12861057 | *[[PSAP]] -ve.<ref name=pmid12861057/> | ||
*CK34betaE12 +ve/-ve (diffuse +ve in 4/7 cases) | *[[CK34betaE12]] +ve/-ve (diffuse +ve in 4/7 cases) | ||
*p63 -ve. | *[[p63]] -ve. | ||
*AMACR +ve (focal). | *[[AMACR]] +ve (focal). | ||
==See also== | ==See also== | ||
*[[Prostate gland]]. | *[[Prostate gland]]. | ||
*[[Prostate cancer]]. | *[[Prostate cancer]]. | ||
*[[Nephrogenic adenoma]]. | |||
==References== | ==References== |
edits